Search keyWord :

Linker Vision Unveils the Future of Smart Cities at CES 2025: Showcasing Innovative VLM and GenAI

LAS VEGAS,Jan. 8,2025-- Linker Vision revealed its groundbreaking technologies at CES 2025,featuring its latest GenAI Observ platform,VLM (Vision Language Model),and LVM (Large Vision Model). The comp

Jan 8, 2025

Axonify Receives Gold and Silver in Brandon Hall Group's 2024 Excellence in Technology Awards

Recognized with Gold Award for "Best Advance in Learning Management Measurement/Business Impact Tools," Silver Award for "Best Advance in a Generative AI Solution"

Jan 8, 2025

Webull Canada Celebrates First Anniversary

TORONTO,Jan. 7,2025-- Webull Canada,a subsidiary of Webull Corporation,the owner of the popular Webull digital investment platform,is proudly celebrating its first anniversary after a year of rapid g

Jan 8, 2025

Avenzo Therapeutics and DualityBio Announce Exclusive Global License for Potential Best-In-Class EGFR/HER3 Antibody-Drug Conjugate

Avenzo to receive exclusive global license (excluding Greater China) for development,manufacturing and commercialization of potential best-in-class EGFR/HER3 antibody-drug conjugate

Jan 8, 2025

Two New Products at CES: Hesai Showcases 1440-Channel Automotive Lidar and Next Gen Solid-State Lidar

Hesai (Nasdaq: HSAI) introduces new AT1440 with the world\'s highest number of channels for an automotive lidar and the FTX solid-state lidar with the world\'s widest field of view

Jan 8, 2025

Hesai Unveils Mini Hyper-Hemispherical 3D Lidar Series for Robotics at CES

Hesai (Nasdaq: HSAI) introduces new JT series mini 3D lidar,with compact and lightweight design,and world\'s widest hyper-hemispherical field of view

Jan 8, 2025

IntouchCX Expands Trust & Safety Solutions With Strategic Acquisition Of Webpurify

WINNIPEG,MB,Jan. 8,2025-- IntouchCX today announced its acquisition of WebPurify,a premier provider of AI-powered and human-driven content moderation solutions. This acquisition marks a milestone in I

Jan 8, 2025

Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease

Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups,demonstrating a favorable PK profile in validating gut-r

Jan 8, 2025

MedicosBiotech Wins CES 2025 Innovation Award in Digital Health

SEOUL,South Korea,Jan. 8,2025-- MedicosBiotech proudly announces its recognition at CES 2025,the world\'s premier technology event,as a recipient of the prestigious CES Innovation Award in the Digital

Jan 8, 2025

viaim Redefines Conference Efficiency with the Official North American Launch of AI-Powered RecDot Earbuds at CES 2025

Marking a new era of work efficiency,the innovative smart office tools are available at a 5% discount for a limited time.

Jan 8, 2025
1 ... 542 543 544 545 546 547 548 ... 1318

Singapore Technology Information: Your Source for Tech, AI, Aerospace, Biotech News

© Singapore Technology Information Privacy Policy Contact us

Singapore Technology Information is an advanced technology news portal. Committed to reporting on the latest developments in technology, artificial intelligence, biotechnology, data and other fields.